---
title: "TD Cowen Reaffirms Their Buy Rating on Aurinia Pharmaceuticals (AUPH)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291837722.md"
description: "TD Cowen analyst Stacy Ku reaffirmed a Buy rating on Aurinia Pharmaceuticals (AUPH) with a $17.00 price target. Ku, a 4-star analyst in the Healthcare sector, maintains this stance alongside an overall Moderate Buy consensus for AUPH, which has a consensus price target of $15.67."
datetime: "2026-07-06T19:35:13.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291837722.md)
  - [en](https://longbridge.com/en/news/291837722.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291837722.md)
generator: "portal-rs"
---

# TD Cowen Reaffirms Their Buy Rating on Aurinia Pharmaceuticals (AUPH)

TD Cowen analyst Stacy Ku maintained a Buy rating on Aurinia Pharmaceuticals today and set a price target of $17.00.

### 4th of July Sale - 70% Off

-   Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
-   Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.

According to TipRanks, Ku is a 4-star analyst with an average return of 13.3% and a 59.06% success rate. Ku covers the Healthcare sector, focusing on stocks such as Tonix Pharma, Protara Therapeutics, and Supernus Pharmaceuticals.

Aurinia Pharmaceuticals has an analyst consensus of Moderate Buy, with a price target consensus of $15.67.

### Related Stocks

- [AUPH.US](https://longbridge.com/en/quote/AUPH.US.md)
- [TNXP.US](https://longbridge.com/en/quote/TNXP.US.md)
- [TARA.US](https://longbridge.com/en/quote/TARA.US.md)
- [SUPN.US](https://longbridge.com/en/quote/SUPN.US.md)

## Related News & Research

- [Diamond Hill Capital Management LLC Investment Advisor Purchases New Position in Aurinia Pharmaceuticals Inc $AUPH](https://longbridge.com/en/news/296195979.md)
- [Aurinia Pharmaceuticals and Teva Settle Patent Dispute for Kidney Disease Drug](https://longbridge.com/en/news/296500759.md)
- [BioCryst Pharmaceuticals (BCRX), What Is Behind The Fresh Attention Now?](https://longbridge.com/en/news/296688974.md)
- [Aurinia settles Teva patent suit, sets generic voclosporin launch no earlier than Dec. 7, 2036](https://longbridge.com/en/news/296394736.md)
- [$100 Invested In Ligand Pharmaceuticals 10 Years Ago Would Be Worth This Much Today](https://longbridge.com/en/news/296632631.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**